ICAD Inc
NASDAQ:ICAD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
ICAD Inc
Free Cash Flow
ICAD Inc
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
ICAD Inc
NASDAQ:ICAD
|
Free Cash Flow
-$2.8m
|
CAGR 3-Years
36%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Free Cash Flow
$1.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
21%
|
CAGR 10-Years
37%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Free Cash Flow
$78.5m
|
CAGR 3-Years
217%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Free Cash Flow
$266.7m
|
CAGR 3-Years
30%
|
CAGR 5-Years
65%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Free Cash Flow
$66.9m
|
CAGR 3-Years
58%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
14%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Free Cash Flow
$283.2m
|
CAGR 3-Years
49%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ICAD Inc
Glance View
iCAD, Inc. is a medical technology company, which engages in the provision cancer detection and therapy solutions. The company is headquartered in Nashua, New Hampshire and currently employs 136 full-time employees. The firm operates through two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). In the Detection segment, the Company’s solutions include advanced image analysis and workflow solutions enables healthcare professionals to serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, and a comprehensive range of artificial intelligence and computer aided detection (CAD) systems and workflow solutions for two-dimension(2D) and third dimension (3D) mammography, magnetic resonance imaging (MRI) and computed tomography (CT). In the Therapy segment, the Company offers the Xoft System, an isotope-free cancer treatment platform technology. The Xoft System can be used for the treatment of early-stage breast cancer, endometrial cancer, cervical cancer and nonmelanoma skin cancer.
See Also
What is ICAD Inc's Free Cash Flow?
Free Cash Flow
-2.8m
USD
Based on the financial report for Mar 31, 2025, ICAD Inc's Free Cash Flow amounts to -2.8m USD.
What is ICAD Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
17%
Over the last year, the Free Cash Flow growth was 50%. The average annual Free Cash Flow growth rates for ICAD Inc have been 36% over the past three years , 17% over the past five years .
